Expertise
Digital Therapeutics and Health Technology (DTxHT)
The most impactful and up-to-date value, access, reimbursement and policy insights within the digital healthcare space.
Digital health technologies are evolving rapidly and are playing an increasingly significant role in both the companion diagnostic and treatment paradigms. Trinity’s experts draw upon their deep understanding of access and reimbursement decision-making for traditional therapeutics to identify and analyze the most impactful events and landscape shifts in the digital space.
Trinity’s DTxHT knowledge resource hub releases regular up-to-date insights about policy updates, assessment routes, and funding pathways to support our clients in securing future strategic success. Some business challenges that we can support with include:
- Introducing new technologies that follow different funding pathways (e.g., self-pay, employer-sponsored, or public or private insurance funding)
- Understanding new HTA frameworks that evaluate the evidence supporting the effectiveness of digital health solutions
- Navigating the hurdles of proving the value of DTx through real-world-evidence
Follow Trinity on LinkedIn to receive exclusive updates that are native to the channel or read our latest thought leadership here.
Latest DTxHT Intelligence
Blog
ISPOR 2023 Trinity Panel: Enabling Patient Access to Digital Therapeutics – The Optimal Approach?
Monica Martin de Bustamante, Sr. Partner of Trinity’s Evidence, Value, Access, and Pricing (EVAP) team, moderated an exciting conversation at ISPOR 2023 Global in Boston earlier this month. Monica spoke with Lisa Marsch, Ph.D., Benjamin Parcher, PharmD, MS, and Fulton Velez, MD, MS, MBA, all experts in the field of Digital Therapeutics (DTx), about the […]
Read More
Webinars
Payer Predictions: Evolution of the U.S. Digital Therapeutics Reimbursement Landscape
Available On Demand
The digital therapeutics (DTx) market is growing rapidly, but a lack of clarity around their reimbursement framework in the U.S. means that there is limited coverage. DTx developers— and pharmaceutical organizations seeking an integrated digital offering— are left to wonder how the payer landscape will evolve as they strategize for the future. Join Trinity Life […]
Watch Now
White Papers
Reimbursement of Digital Therapeutics in the U.S.
Digital therapeutics (DTx) are impacting how patients are treated, interact with their providers and think about their own health. DTx have garnered interest from the investment community as well as pharma companies seeking an integrated digital offering. However, payers have not yet established a clear framework for integrating these technologies in their plans. Coverage of […]
Read More
If you have any questions, we’re here to answer them.
We look forward to helping identify solutions for you.